A Phase 2 Study to Evaluate the Efficacy and Safety of LY03020 in Acutely Psychotic Participants With Schizophrenia
Clinical trial NCT07396870 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07396870
- Sponsor
- Luye Pharma Group Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-31
- Primary completion
- 2027-12-31
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.